STRATEGIES IN THE CRYSTALLIZATION OF GLYCOPROTEINS AND PROTEIN COMPLEXES

被引:109
作者
STURA, EA [1 ]
NEMEROW, GR [1 ]
WILSON, IA [1 ]
机构
[1] SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/0022-0248(92)90256-I
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
Modern biochemical and molecular biological techniques have provided new opportunities to investigate the structure of more complex biomolecules and have opened new paths for the crystallization of complexes. Desialation, deglycosylation and modification of glycoproteins are techniques being investigated as a means of making glycosylated proteins more amenable for crystallization. A simple solubility screen based on a limited set of precipitants has been extensively used in the comparison of various protein preparations and in the crystallization of macromolecular complexes. Antibodies, or their Fabs or Fab' fragments, can also be utilized in the crystallization of glycoproteins or other proteins which have proved difficult to crystallize by themselves. Fab complexes can provide different surfaces for lattices to form and may increase the likelihood of crystallizing a given protein. This method can be extended by the addition of an epitope tag, such as a short peptide sequence, to a protein by genetic engineering methods. The same panel of anti-peptide antibodies can then be utilized in both the purification and crystallization of different expressed proteins, making this a potential general method for protein crystallization.
引用
收藏
页码:273 / 285
页数:13
相关论文
共 51 条
[1]  
ALEXANDER S, 1989, METHOD ENZYMOL, V179, P505
[2]   INITIATION OF COAGULATION BY TISSUE FACTOR [J].
BACH, RR .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1988, 23 (04) :339-368
[3]  
BROZE GJ, 1985, J BIOL CHEM, V260, P917
[4]  
CAREL JC, 1990, J BIOL CHEM, V265, P12293
[5]  
CARTER CW, 1979, J BIOL CHEM, V254, P2219
[6]  
DEVOS AM, 1985, P NATL ACAD SCI USA, V82, P1406
[7]  
EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67
[8]  
ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540
[9]   PURIFICATION OF A RAS-RESPONSIVE ADENYLYL CYCLASE COMPLEX FROM SACCHAROMYCES-CEREVISIAE BY USE OF AN EPITOPE ADDITION METHOD [J].
FIELD, J ;
NIKAWA, J ;
BROEK, D ;
MACDONALD, B ;
RODGERS, L ;
WILSON, IA ;
LERNER, RA ;
WIGLER, M .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (05) :2159-2165
[10]   EPSTEIN-BARR VIRUS RECEPTOR OF HUMAN LYMPHOCYTES-B IS THE C3D RECEPTOR CR-2 [J].
FINGEROTH, JD ;
WEIS, JJ ;
TEDDER, TF ;
STROMINGER, JL ;
BIRO, PA ;
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14) :4510-4514